Article
Use of JAK Inhibitors in Lichen Planus: An Update
8 Jun 2025
Abstract excerpt
Lichen planus (LP) is a chronic inflammatory disorder affecting approximately 1% of the population. It presents with a wide range of clinical manifestations, mainly involving the skin, mucosal surfaces, and skin appendages, and is often characterized by a relapsing course and variable response to treatment. Although several therapeutic strategies are available, many are off-label and show limited efficacy in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
